Content
All Posts > Content under Pharma/Biotech
5 Biotechs In Search Of A Coronavirus Vaccine
Article By:
MoneyShow.com
Read
Friday, March 20, 2020 8:36 AM EDT
In serious situations like this, the FDA would certainly fast-track any promising cure or vaccine that is submitted. But even that implies a lengthy delay. Many companies are racing to be the first out of the gate. Here are some of them.
Cannabis Central: Sector Up 7.5% On Thursday; Both Tilray And Hexo Were Up 56%
Article By:
Lorimer Wilson
Read
Friday, March 20, 2020 4:32 AM EDT
The cannabis stock sector went up 7.5%, on average, Thursday with 15 such non-penny stocks going up 7.5% or more, 6 going down 2.5% or more with another 15 non-penny pot stocks worthy of mention.This article highlights those stocks.
Soligenix Announces Positive Top-line Results For Its Pivotal Phase 3 FLASH Trial Evaluating SGX301 In Treatment Of Cutaneous T-Cell Lymphoma
Article By:
TalkMarkets Newswire
Read
Thursday, March 19, 2020 6:32 AM EDT
Soligenix announced positive preliminary top-line results for its pivotal Phase 3 FLASH trial evaluating SGX301 in the treatment of cutaneous T-cell lymphoma. The company will host an Investor Conference Call today at 8:30AM EDT,
In this article: SNGX
Cannabis Stock Sector Continues To Crater: Declined 10.2% On Wednesday
Article By:
Lorimer Wilson
Read
Thursday, March 19, 2020 5:20 AM EDT
The cannabis stock sector declined 10.2% on Wednesday and has now dropped 61.1% in the past 2 months and 84.1% from its peak price a year ago. No major pot stocks advanced in price Wednesday..
3 Hot Biotech Coronavirus Stocks Breaking Out Now
Article By:
Deron Wagner
Read
Thursday, March 19, 2020 1:00 AM EDT
A massive amount of technical damage has been done to top leading stock charts lately, eliminating most low-risk buying opportunities.
Coronavirus Fears Drive Telemedicine Stocks
Article By:
Eddy Elfenbein
Read
Wednesday, March 18, 2020 6:02 AM EDT
Coronavirus cases continue to grow in the United States, as expected. Here are a few companies that hold up well in this market, have outstanding growth overall, and should continue to benefit from telemedicine offering.
Cannabis Central: Crash Continues Unabated - Sector Was Down 11.2% On Monday
Article By:
Lorimer Wilson
Read
Tuesday, March 17, 2020 4:47 AM EDT
Cannabis stocks crashed 11.2%, on average, yesterday, with only 1 non-penny stock bucking the trend while 12 such stocks declined by more than 15%. To put things in perspective, the S&P 500 declined 10.9%, in comparison.
Week In Review: Nanjing Legend Files To Stage IPO In The US
Article By:
ChinaBio® Today
Read
Saturday, March 14, 2020 6:05 PM EDT
Nanjing Legend Biotech, a subsidiary of GenScript, has filed for an IPO on a US exchange. In 2017, Legend surprised the world when its CAR-T therapy produced a 94% response rate in pretreated multiple myeloma patients.
Centogene - All Time High
Article By:
Jim Van Meerten
Read
Wednesday, March 11, 2020 7:42 PM EDT
Revenue expected to grow 28.40% next year. Earnings estimated to increase 58.10% next year
In this article: CNTG
Market Briefing For Wednesday, March 11
Article By:
Gene Inger
Read
Wednesday, March 11, 2020 4:20 AM EDT
Hurried interventions to stem-the-outflow weren't refined, but sprung on officials by the President, and though they are understaffed by smart people (including in the healthcare realm), this was welcomed of course.